794
Views
63
CrossRef citations to date
0
Altmetric
Review

Mycophenolate mofetil for non‐renal manifestations of systemic lupus erythematosus: a systematic review

Pages 329-337 | Accepted 04 Jul 2007, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Nathaniel Goldman, Joseph Han & Avery LaChance. (2022) Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases. Clinical, Cosmetic and Investigational Dermatology 15, pages 2285-2312.
Read now
Yuichiro Fujieda. (2020) Diversity of neuropsychiatric manifestations in systemic lupus erythematosus. Immunological Medicine 43:4, pages 135-141.
Read now
Natasha Jordan & David D’Cruz. (2016) Current and emerging treatment options in the management of lupus. ImmunoTargets and Therapy 5, pages 9-20.
Read now
Antonis Fanouriakis, Dimitrios T Boumpas & George K Bertsias. (2011) Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus. Expert Review of Clinical Pharmacology 4:4, pages 437-451.
Read now
Yoshie Kusunoki, Nahoko Tanaka, Kaichi Kaneko, Tatsuhiro Yamamoto, Hirahito Endo & Shinichi Kawai. (2009) Tacrolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study. Modern Rheumatology 19:6, pages 616-621.
Read now

Articles from other publishers (58)

Saleha Dar, Sabina Koirala, Arooba Khan, Mounika Deepthi Bellary, Arya V Patel, Bejoi Mathew, Rahul Singh, Nahida Baigam, Waleed Razzaq, Zain U Abdin & Uzzam Ahmed Khawaja. (2023) A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations. Cureus.
Crossref
Panagiotis Athanassiou & Lambros Athanassiou. (2023) Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus. Life 13:7, pages 1496.
Crossref
Rithika Bhat, Antonio Tonutti, Suraj Timilsina, Carlo Selmi & M. Eric Gershwin. (2023) Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity. Clinical Reviews in Allergy & Immunology 65:1, pages 86-100.
Crossref
Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D. Poole, Daniela Baracaldo-Santamaría & Claudia M. Tellez Freitas. (2022) Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety. Medicina 59:1, pages 56.
Crossref
Mickaël Roussotte, Mathieu Gerfaud-Valentin, Arnaud Hot, Sylvain Audia, Bernard Bonnotte, Thomas Thibault, Hervé Lobbes, Guillaume Le Guenno, Radjiv Goulabchand, Pascal Cathebras, Loig Varron, Jean François Dufour, Alban Deroux, Caroline Compain, Antoine Baudet, Ludovic Karkowski, Laurent Pérard, Mikael Ebbo, Jean-Christophe Lega & Pascal Sève. (2022) Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients. Rheumatology 61:9, pages 3627-3639.
Crossref
Masahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, Mitsuteru Akahoshi, Nobuyuki Ono, Yojiro Arinobu, Koichi Akashi, Takahiko Horiuchi & Hiroaki Niiro. (2022) Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210963.
Crossref
Giulio Olivieri, Fulvia Ceccarelli, Francesco Natalucci, Carmelo Pirone, Valeria Orefice, Viviana Antonella Pacucci, Cristina Garufi, Simona Truglia, Francesca Romana Spinelli, Cristiano Alessandri & Fabrizio Conti. (2021) Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus: Comparison between renal and non-renal involvement. Joint Bone Spine 88:6, pages 105246.
Crossref
Panagiotis Athanassiou, Lambros Athanassiou & Ifigenia Kostoglou-Athanassiou. 2021. Lupus - Need to Know. Lupus - Need to Know.
Elizabeth E. Cooper, Catherine E. Pisano & Samantha C. Shapiro. (2021) Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond. International Journal of Rheumatology 2021, pages 1-19.
Crossref
Cora W Hannon, Collette McCourt, Hermenio C Lima, Suephy Chen & Cathy Bennett. (2021) Interventions for cutaneous disease in systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2021:3.
Crossref
Zhi-Hui Xiong, Xiao-Song Cao, Hai-Lian Guan & Hui-Ling Zheng. (2020) Immunotherapies application in active stage of systemic lupus erythematosus in pregnancy: A case report and review of literature. World Journal of Clinical Cases 8:24, pages 6396-6407.
Crossref
Mengtao Li, Yan Zhao, Zhiyi Zhang, Cibo Huang, Yi Liu, Jieruo Gu, Xiao Zhang, Huji Xu, Xiaofeng Li, Lijun Wu, Yijun Song, Xuemei Li, Hongzhong Jin, Junqiang Lei, Yaolong Chen & Xiaofeng Zeng. (2020) 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Rheumatology and Immunology Research 1:1, pages 5-23.
Crossref
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg Bajema, John N Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni, Frédéric Houssiau, David Jayne, Marios Kouloumas, Annegret Kuhn, Janni L Larsen, Kirsten Lerstrøm, Gabriella Moroni, Marta Mosca, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Vladimir Tesar, Angela Tincani, Anne Troldborg, Ronald van Vollenhoven, Jörg Wenzel, George Bertsias & Dimitrios T Boumpas. (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases 78:6, pages 736-745.
Crossref
Ruba Kado & W. Joseph McCune. (2019) Treatment of primary and secondary immune thrombocytopenia. Current Opinion in Rheumatology 31:3, pages 213-222.
Crossref
Ui Hong Jung, Sang Gyu Kwak, Jung-Yoon Choe, Shin-Seok Lee & Seong-Kyu Kim. (2019) The Effect of Mycophenolate Mofetil on Non-Renal Manifestations in Systemic Lupus Erythematosus: Results from Korean Lupus Network Registry. Journal of Korean Medical Science 34:27.
Crossref
Andrea Fava & Michelle Petri. (2019) Systemic lupus erythematosus: Diagnosis and clinical management. Journal of Autoimmunity 96, pages 1-13.
Crossref
Gabriella Moroni, Paolo Gilles Vercelloni, Silvana Quaglini, Mariele Gatto, Davide Gianfreda, Lucia Sacchi, Francesca Raffiotta, Margherita Zen, Gloria Costantini, Maria Letizia Urban, Federico Pieruzzi, Piergiorgio Messa, Augusto Vaglio, Renato Alberto Sinico & Andrea Doria. (2018) Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Annals of the Rheumatic Diseases 77:9, pages 1318-1325.
Crossref
Jessica Neely & Emily von Scheven. (2018) Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment. Current Opinion in Rheumatology 30:5, pages 498-505.
Crossref
Caroline GordonMaame-Boatemaa Amissah-ArthurMary GayedSue BrownIan N. BruceDavid D’CruzBenjamin EmpsonBridget GriffithsDavid JayneMunther KhamashtaLiz LightstonePeter Norton, Yvonne Norton, Karen SchreiberDavid Isenberg. (2018) The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology 57:1, pages e1-e45.
Crossref
Josep Ordi-Ros, Luis Sáez-Comet, Mercedes Pérez-Conesa, Xavier Vidal, Francesca Mitjavila, Antoni Castro Salomó, Jordi Cuquet Pedragosa, Vera Ortiz-Santamaria, Montserrat Mauri Plana & Josefina Cortés-Hernández. (2017) Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial. Annals of the Rheumatic Diseases 76:9, pages 1575-1582.
Crossref
Vaidehi R. Chowdhary. (2017) Broad Concepts in Management of Systemic Lupus Erythematosus. Mayo Clinic Proceedings 92:5, pages 744-761.
Crossref
Laurie S. Davis & Andreas M. Reimold. (2017) Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus. Rheumatology 56:suppl_1, pages i100-i113.
Crossref
Konstantinos Tselios, Dafna D. Gladman, Jiandong Su & Murray B. Urowitz. (2016) Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study. The Journal of Rheumatology 43:3, pages 552-558.
Crossref
César Magro-Checa, Elisabeth J. Zirkzee, Tom W. Huizinga & Gerda M. Steup-Beekman. (2016) Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs 76:4, pages 459-483.
Crossref
Efrosini Papagiannuli, Benjamin Rhodes, Graham R. Wallace, Caroline Gordon, Philip I. Murray & Alastair K. Denniston. (2016) Systemic lupus erythematosus: An update for ophthalmologists. Survey of Ophthalmology 61:1, pages 65-82.
Crossref
Josefina Cortés-Hernández, Natalia Egri, Miquel Vilardell-Tarrés & Josep Ordi-Ros. (2015) Etanercept in refractory lupus arthritis: An observational study. Seminars in Arthritis and Rheumatism 44:6, pages 672-679.
Crossref
Sarah J Strathie Page & Clare P Tait. (2015) Mycophenolic acid in dermatology a century after its discovery. Australasian Journal of Dermatology 56:1, pages 77-83.
Crossref
Daniel J. Wallace. 2015. Rheumatology. Rheumatology 1099 1106 .
Pamela M.K. Lutalo, Natasha Jordan & David P. D’Cruz. (2014) Which dose of steroids and which cytotoxics for severe lupus?. La Presse Médicale 43:6, pages e157-e165.
Crossref
Sofia Sapeta Dias & David A. Isenberg. (2014) Advances in systemic lupus erythematosus. Medicine 42:3, pages 126-133.
Crossref
Veronica Rodriguez-Garcia, Sofia Sapeta Dias & David Isenberg. (2014) Recent advances in the treatment of systemic lupus erythematosus. International Journal of Clinical Rheumatology 9:1, pages 89-100.
Crossref
M. Aringer, R. Fischer-Betz & F. Hiepe. (2013) Stellungnahme zum Einsatz von Mycophenolat-Mofetil beim systemischen Lupus erythematodesStatement on the use of mycophenolate mofetil for systemic lupus erythematosus. Zeitschrift für Rheumatologie 72:6, pages 575-580.
Crossref
Kam Newman, Mohammad Bagher Owlia, Ihab El-Hemaidi & Mojtaba Akhtari. (2013) Management of immune cytopenias in patients with systemic lupus erythematosus — Old and new. Autoimmunity Reviews 12:7, pages 784-791.
Crossref
George Bertsias, Antonios Fanouriakis & Dimitrios T. Boumpas. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology 1304 1330.e6 .
N. Ranawaka, I. Atukorala, N. Fernandopulle & M. Nawarathna. (2012) An unusual cause of generalized oedema in systemic lupus erythematosus. Rheumatology 51:12, pages 2298-2300.
Crossref
Bruce E. Strober, Jennifer Clay Cather, David Cohen, Jeffrey J. Crowley, Kenneth B. Gordon, Alice B. Gottlieb, Arthur F. Kavanaugh, Neil J. Korman, Gerald G. Krueger, Craig L. Leonardi, Sergio Schwartzman, Jeffrey M. Sobell, Gary E. Solomon & Melodie Young. (2012) A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1. Dermatology and Therapy 2:1.
Crossref
G. Lefèvre, H. Zéphir, E. Michelin, F. Semah, F. Warembourg, J.-P. Pruvo, E. Hachulla, P. Lenfant, S. Dubucquoi, P. Vermersch, P.-Y. Hatron, L. Prin & D. Launay. (2012) Neurolupus (2e partie). Description des outils diagnostiques et thérapeutiques devant une manifestation psychiatrique ou neurologique centrale au cours du lupus érythémateux systémique. La Revue de Médecine Interne 33:9, pages 503-513.
Crossref
María Verónica Reyes & Francisco Vanaclocha Sebastián. (2012) Tratamiento del lupus eritematoso cutáneo resistente. Seminarios de la Fundación Española de Reumatología 13:3, pages 77-84.
Crossref
Taryn Pile, Julius Kieswich, Steven Harwood & Muhammad M. Yaqoob. (2011) A Possible Explanation for Anemia in Patients Treated With Mycophenolic Acid. Transplantation 92:12, pages 1316-1321.
Crossref
Matteo Piga & Alessandro Mathieu. (2011) Managing CNS involvement in systemic lupus erythematosus. International Journal of Clinical Rheumatology 6:5, pages 547-567.
Crossref
Maria Dall’Era. (2011) Mycophenolate mofetil in the treatment of systemic lupus erythematosus. Current Opinion in Rheumatology 23:5, pages 454-458.
Crossref
Alana B. Levine & Doruk Erkan. (2011) Clinical Assessment and Management of Cytopenias in Lupus Patients. Current Rheumatology Reports 13:4, pages 291-299.
Crossref
. 2011. Andrews' Diseases of the Skin. Andrews' Diseases of the Skin 155 181 .
Michael Sticherling. 2011. Autoimmune Diseases of the Skin. Autoimmune Diseases of the Skin 193 213 .
Maame B. Amissah-ArthurCaroline Gordon. (2010) Contemporary treatment of systemic lupus erythematosus: an update for clinicians. Therapeutic Advances in Chronic Disease 1:4, pages 163-175.
Crossref
Sharmin Nizam & Andrew Gough. (2010) Psychosis in a young female – a diagnostic and therapeutic challenge. JRSM Short Reports 1:3, pages 1-4.
Crossref
S. M. Breathnach, C. H. Smith, R. J. G. Chalmers & R. J. Hay. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology 1 53 .
M. J. D. Goodfield, S. K. Jones & D. J. Veale. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology 1 138 .
Ellen M. Ginzler, David Wofsy, David Isenberg, Caroline Gordon, Laura Lisk & Mary‐Anne Dooley. (2009) Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open‐label, parallel‐group clinical trial. Arthritis & Rheumatism 62:1, pages 211-221.
Crossref
Hobart W. Walling & Richard D. Sontheimer. (2009) Cutaneous Lupus Erythematosus. American Journal of Clinical Dermatology 10:6, pages 365-381.
Crossref
M Yamamoto, HM Belmont, M Utsunomiya, Y Hidaka & M Kishimoto. (2009) Gelatinous transformation of the bone marrow in systemic lupus erythematosus. Lupus 18:12, pages 1108-1111.
Crossref
JD Posalski, ML Ishimori, DJ Wallace & MH Weisman. (2009) Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years. Lupus 18:6, pages 516-521.
Crossref
Fernando Martínez Valle, Josep Ordi-Ros & Miquel Vilardell-Tarrés. (2009) Manifestaciones neuropsiquiátricas en el lupus eritematoso sistémico. Medicina Clínica 132:20, pages 797-801.
Crossref
Chi Chiu Mok. (2009) Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma. Nature Reviews Nephrology 5:4, pages 212-220.
Crossref
F Falcini, S Capannini, G Martini, F La Torre, A Vitale, F Mangiantini, F Nacci, MM Cerinic, R Cimaz & F Zulian. (2009) Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. Lupus 18:2, pages 139-143.
Crossref
Catherine A. Heyneman. (2008) Systemic Lupus Erythematosus: A Therapeutic Update. Journal of Pharmacy Practice 22:1, pages 29-52.
Crossref
Alissa K. Orvis, Stanton K. Wesson, Thomas S. BrezaJr.Jr., Ann A. Church, Christina L. Mitchell & Shannon W. Watkins. (2009) Mycophenolate mofetil in dermatology. Journal of the American Academy of Dermatology 60:2, pages 183-199.
Crossref
Lauren M. Pachman. 2009. The Inflammatory Myopathies. The Inflammatory Myopathies 55 86 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.